Month: June 2018

APTINYX, Inc. #IPO Preview ($APTX)

Company: Aptinyx, Inc. Symbol: APTX Description: They are a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Trade Date: 6/21 Shares: 5.33 million Price Range: $14.00-$16.00 Underwriter(s): J.P. Morgan, Cowen, Leerink Partners, BMO Capital Markets Terms Added: 6-11-18[…]

AVROBIO, Inc. #IPO Preview ($AVRO)

Company: AVROBIO, Inc. Symbol: AVRO Description: They are a clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose. Trade Date: 6/21 Shares: 4.4 million Price Range: $16.00-$18.00 Underwriter(s): Morgan Stanley, Cowen, Wells Fargo Securities Co-Manager(s): Wedbush Pacgrow Terms Added: 6-11-18 Link[…]

Kezar Life Sciences, Inc. #IPO Preview ($KZR)

Company: Kezar Life Sciences, Inc. Symbol: KZR Description: They are a clinical-stage biotechnology company, discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. Trade Date: 6/21 Shares: 4.67 million Price Range: $14.00-$16.00 Underwriter(s): Jefferies, Cowen, Wells Fargo, William Blair Terms Added: 6-8-18 Link to Prospectus Link to Retail Roadshow[…]

I3 Verticals, Inc. #IPO Preview ($IIIV)

Company: i3 Verticals, Inc. Symbol: IIIV Description: They deliver seamless integrated payment and software solutions to small- and medium-sized businesses and organizations in strategic vertical markets. Trade Date: 6/21 Shares: 6.65 million Price Range: $11.00-$13.00 Underwriter(s): Cowen, Raymond James, KeyBanc Capital Markets Terms Added: 6-11-18 Link to Prospectus Link to Retail Roadshow Business: They have built[…]

Magenta Therapeutics #IPO Preview ($MGTA)

Company: Magenta Therapeutics, Inc. Symbol: MGTA Description: They are a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patients. Trade Date: 6/21 Shares: 6.67 million Price Range: $14.00-$16.00 Underwriter(s): J.P. Morgan, Goldman Sachs, Cowen Co-Manager(s): Wedbush PacGrow Terms Added: 6-8-18 Link to Prospectus Link to Retail[…]

Xeris Pharmaceuticals #IPO Preview ($XERS)

Company: Xeris Pharmaceuticals, Inc. Symbol: XERS Description: They are a specialty pharmaceutical company leveraging our novel non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize ready-to-use injectable and infusible drug formulations. Trade Date: 6/21 Shares: 5 million Price Range: $14.00-$16.00 Underwriter(s): Jefferies, Leerink Partners, RBC Capital, Mizuho Securities Terms Added: 6-11-18 Link to[…]

Autolus Therapeutics #IPO Preview ($AUTL)

Company: Autolus Therapeutics Limited Symbol: AUTL Description: They are a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. Trade Date: 6/22 Shares: 7.81 million Price Range: $15.00-$17.00 Underwriter(s): Goldman Sachs & Co., Jefferies Co-Manager(s): Wells Fargo Securities, William Blair Terms Added: 6-8-18 Link to Prospectus Link to Retail Roadshow Business: They[…]

Electrocore #IPO Preview ($ECOR)

Company: Electrocore, LLC Symbol: ECOR Description: They are a commercial-stage bioelectronic medicine company with a platform non-invasive vagus nerve stimulation therapy initially focused on neurology and rheumatology. Trade Date: 6/22 Shares: 4.33 million Price Range: $14.00-$16.00 Underwriter(s): Evercore ISI, JMP Securities, BTIG Terms Added: 6-5-18 Link to Prospectus Link to Retail Roadshow Business: They are a[…]

Secondaries Announced 6.11.18

IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]

IPO Pipeline Update – Ending 6.08.18

IPO Boutique keeps apprised of the active pipeline. Currently there are 76 active IPOs in the pipeline as of June 8, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article. NEW FILINGS Company: Forty[…]

IPO Weekly Recap: Opening week of June starts slow

Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and[…]

Weekly Secondary Performance (6.8.18)

IPO BOUTIQUE is one of the few syndicate services that provides ratings on all secondary offerings (Spots, blocks, marketed). We use our database of historical performances, underwriter trends and more than 40 years of syndicate experience to give our clients a leg up. We meticulously keep records of our ratings. If interested please click below to[…]

Verrica Pharmaceuticals #IPO Preview

Company: Verrica Pharmaceuticals Inc. Symbol: VRCA Description: They are a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. Trade Date: 6/15 Shares: 5 million Price Range: $14.00-$16.00 Underwriter(s): BofA Merrill Lynch, Jefferies, Cowen Terms Added: 6-5-18 Link to Prospectus Link[…]

Puxin Limited #IPO Preview ($NEW)

Company: Puxin Limited Symbol: NEW Description: They are a successful consolidator of the after-school education industry in China. Trade Date: 6/15 Shares: 7.2 million Price Range: $17.00-$20.00 Underwriter(s): Citigroup, Deutsche Bank, Barclays, Haitong International, CICC Terms Added: 6-1-18 Link to Prospectus Link to Retail Roadshow Business: They are a successful consolidator of the after-school education industry[…]

Avalara Inc #IPO Preview ($AVLR)

Company: Avalara, Inc. Symbol: AVLR Description: They provide a leading suite of cloud-based solutions designed to improve accuracy and efficiency by automating the processes of determining taxability, identifying applicable tax rates, determining and collecting taxes, preparing and filing returns, remitting taxes, maintaining tax records, and managing compliance documents. Trade Date: 6/15 Shares: 7.5 million Price[…]

U.S. Xpress Enterprises, Inc. #IPO Preview (USX)

Company: U.S. Xpress Enterprises, Inc. Symbol: USX Description: They are the fifth largest asset-based truckload carrier in the United States by revenue, generating over $1.5 billion in total operating revenue in 2017. Trade Date: 6/14 Shares: 18.05 million Price Range: $18.00-$20.00 Underwriter(s): BofA Merrill Lynch, Morgan Stanley, J.P. Morgan, Wells Fargo Securities Co-Manager(s): Stephens Inc.,[…]

Charah Solutions, Inc #IPO Preview ($CHRA)

Company: Charah Solutions, Inc. Symbol: CHRA Description: They are a leading provider of mission-critical environmental and maintenance services to the power generation industry. Trade Date: 6/14 Shares: 7.4 million Price Range: $16.00-$18.00 Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Stifel Co-Manager(s): Macquarie Capital, First Analysis Securities, Houlihan Lokey Terms Added: 6-4-18 Link to Prospectus Link to[…]

Adaptive Insights Inc #IPO Preview ($ADIN)

Company: Adaptive Insights, Inc. Symbol: ADIN Description: They are a leading provider of cloud-based software to modernize business planning. Trade Date: 6/14 Shares: 8.2 million Price Range: $13.00-$15.00 Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Jefferies, RBC Capital Co-Manager(s): JMP Securities, Oppenheimer & Co. Terms Added: 6-4-18 Link to Prospectus Link to Retail Roadshow Business: They are[…]

Secondaries Announced 6.4.18

IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]

Scroll to top
error: Content is protected !!